Complications and Adverse Sequelae of Sclerotherapy

Goldman, Mitchel P.

doi:10.1016/b978-0-323-37726-3.00008-3

Cited by 4 publications

(4 citation statements)

References 385 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hyperpigmentation is more common with other sclerosing agents than polidocanol and therefore aesthetically more acceptable especially treating facial lesions. [ 30 ] In a study by Rao et al ,[ 19 ] tissue necrosis and ulceration were found to be more common with STS than with polidocanol and in our study also we did not come across such complications. Anesthesia (surface or local) is required before injecting sclerosants such as STS or ethanolamine oleate, whereas polidocanol being itself a local anesthetic[ 24 ] has added advantage as a sclerosant over others.…”

Section: Discussionsupporting

confidence: 60%

3% Polidocanol sclerotherapy for pyogenic granuloma: Efficacy and safety analysis

Deshpande

Dubey²

2022

J Cutan Aesthet Surg

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 60%

3% Polidocanol sclerotherapy for pyogenic granuloma: Efficacy and safety analysis

Deshpande

Dubey²

2022

J Cutan Aesthet Surg

View full text Add to dashboard Cite

“…Рекомендованные параметры их применения представлены в табл. 2 [58]. Новые разработки включают использование неравномерных импульсных последовательностей, комбинации разных длин волн и короткоимпульсных микросекундных Nd:YAG-лазеров [59,60].…”

Section: размер пятнаunclassified

Percutaneous laser coagulation of dilated intradermal veins: from theory to practice

Bogachev,

Manjikian,

Alukhanyan

2023

Ambulatornaya khirurgiya

View full text Add to dashboard Cite

Review authors consider the current possibilities of percutaneous laser coagulation for telangiectasias and reticular veins, which are the most common cosmetic defects of vascular genesis, occurring in more than 80% of women of different age groups. This vascular pathology constituting an aesthetic defect and causing local physical discomfort is one of the most common indications for phlebosclerosing therapy and percutaneous laser coagulation. The authors present the most effective and safe guidelines for percutaneous laser coagulation based on analyses of a large volume of specialized literature. Due to the use of state-of-the-art Nd:YAG lasers, percutaneous laser coagulation is increasingly used in patients with various types of intradermal vein lesions and, owing to high efficiency and safety, has advantages over compression sclerotherapy by several criteria. Nd:YAG lasers can be divided into long- and short-pulse ones according to their technical characteristics. Long-pulse lasers provide coagulation of the target vessel due to a single pulse with a high energy density (fluence), while short-pulse lasers, on the contrary, generate a series of pulses to the target vein with a running time of fractions of a millisecond, which ensures the conversion of hemoglobin into methemoglobin with a ten-fold increased ability to absorb laser energy and convert it to heat. As the duration of the pulses generated by the device is a priori shorter than the thermal relaxation time, the risk of burns to the skin and paravasal structures almost completely disappears. The authors provide clinical examples of the application of Aerolase Neo device that utilizes MicroPulse technology to confirm the effectiveness and safety of shortpulse Nd:YAG lasers.

show abstract

“…[19] In addition, Entelon ® (Hanlim Pharm Co. Ltd, Seoul, Korea) is a GSPE-based venoactive drug available in Korea for the improvement of symptoms related to CVI. [20,21] GSPE increases venous tone and improves capillary hyperpermeability, fibrinolysis, and lymph and blood flow, thereby inhibiting leukocyte adhesion to endothelial cells and the transmigration of leukocytes into the venous wall. [20,21]…”

Section: Introductionmentioning

confidence: 99%

“…[20,21] GSPE increases venous tone and improves capillary hyperpermeability, fibrinolysis, and lymph and blood flow, thereby inhibiting leukocyte adhesion to endothelial cells and the transmigration of leukocytes into the venous wall. [20,21]…”

Section: Introductionmentioning

confidence: 99%

Pilot study on the effect of grape seed proanthocyanidin extract on inferior vene cava blood flow in patients with chronic venous insufficiency using 4D flow MRI

Jung

Choo

2022

Medicine

View full text Add to dashboard Cite

Background: Four-dimensional (4D) flow magnetic resonance imaging (MRI) was used to objectively assess changes in blood flow velocity in patients with chronic venous insufficiency (CVI) who underwent stocking treatment alone and stocking combined with Grape seed proanthocyanidin extract (GSPE) treatment.Methods: Patients diagnosed with CVI were recruited from August 31, 2018 to December 31, 2020. A total of 23 participants were selected, with 10 and 13 patients in the stocking treatment and stocking + GSPE treatment groups, respectively. The blood flow velocity (Th-plane peak and average velocities) was calculated using 4D flow MRI. A paired t test was used to evaluate the differences in blood flow velocity before and after treatment.Results: In the stocking treatment group, The Th-Plane peak velocity increased by 2.48 ± 5.05 cm/s after treatment (P = .16). In the stocking + GSPE treatment group, the Th-Plane peak velocity increased by 4.85 ± 5.57 cm/s after treatment (P < .001). Conclusion:The blood flow velocity on 4D flow MRI was significantly increased in participants who underwent GSPE, highlighting the potential of GSPE for CVI treatment.

show abstract

Complications and Adverse Sequelae of Sclerotherapy

Cited by 4 publications

References 385 publications

3% Polidocanol sclerotherapy for pyogenic granuloma: Efficacy and safety analysis

3% Polidocanol sclerotherapy for pyogenic granuloma: Efficacy and safety analysis

Percutaneous laser coagulation of dilated intradermal veins: from theory to practice

Pilot study on the effect of grape seed proanthocyanidin extract on inferior vene cava blood flow in patients with chronic venous insufficiency using 4D flow MRI

Contact Info

Product

Resources

About